EuroBiotech Journal, published by SCIENDO, is an essential open-access platform for researchers and professionals in the fields of biomedical engineering, biotechnology, food science, genetics, molecular biology, and molecular medicine. Since its establishment in 2017, the journal has aimed to disseminate high-quality, peer-reviewed research that fosters innovation and collaboration within the European biotechnological landscape and beyond. With its target audience comprising academic scholars, industry practitioners, and students, EuroBiotech Journal has successfully carved a niche, achieving notable Scopus ranks and quartiles, such as Q3 in Biotechnology and Food Science. Based in Warsaw, Poland, the journal welcomes manuscripts that contribute to the vast array of current topics, addressing pressing challenges and discovering solutions pertinent to biotechnology and its applications. As you explore the latest advancements published in this journal, you will find a rich source of knowledge that promotes a deeper understanding of the dynamic and evolving field of biotechnological research.

3 Biotech is a prestigious interdisciplinary journal, published by SPRINGER HEIDELBERG, focusing on the evolving fields of biotechnology, agricultural and biological sciences, and environmental science. With an impressive impact factor and categorized in Q2 across multiple fields in the 2023 rankings, this journal stands out for its contribution to innovative research and its commitment to advancing scientific understanding. Featuring rigorous peer-reviewed articles, it serves as a vital resource for researchers, professionals, and students alike, further enhanced by its significant presence in Scopus rankings. This journal facilitates open discussions and collaborative efforts, aiming to bridge the gap between theoretical research and practical applications in biotechnology. As it continues to publish impactful studies from 2011 to 2024, 3 Biotech is dedicated to shaping the future of biosciences and fostering meaningful scientific advancements.

Applied Microbiology and Biotechnology, an esteemed journal published by Springer, serves as a vital resource in the domains of microbiology and biotechnology. With an impressive impact factor reflecting its quality, the journal holds Q1 rankings in various categories including Applied Microbiology and Biotechnology, Biotechnology, and Medicine (Miscellaneous) as of 2023. Spanning the years from 1984 to 2024, it underscores its commitment to disseminating groundbreaking research that addresses pressing challenges in health, agriculture, and environmental sustainability. The journal is rigorously indexed and holds respectable positions in Scopus rankings, notably within the top 15% of Applied Microbiology and Biotechnology and the top 15% in Biochemistry, Genetics, and Molecular Biology. Although it is not Open Access, its comprehensive articles, reviews, and short communications are indispensable for researchers, professionals, and students eager to advance their understanding and application of microbial processes and biotechnological innovations in real-world contexts.

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

BioTech is a forward-thinking academic journal published by MDPI, specializing in the dynamic fields of applied microbiology, biotechnology, biochemistry, bioengineering, and biomedical engineering. Established for promoting impactful research from 2021 to 2024, this journal aims to bridge the gap between laboratory findings and practical applications, serving as a vital resource for researchers, practitioners, and students alike. With its Open Access model, BioTech ensures that groundbreaking innovations are freely available to the global community, fostering collaboration and knowledge transfer across disciplines. In the 2023 rankings, BioTech holds a strong position in Q2 and Q3 quartiles across various categories, reflecting its commitment to high-quality research output. Being indexed in renowned databases, the journal enhances its visibility and reach, making it a preferred platform for sharing transformative ideas and discoveries in biotechnology and related domains. Set against the backdrop of Switzerland’s thriving research environment, BioTech is poised to become an essential resource in the rapidly evolving landscape of life sciences.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

Industrial Biotechnology, published by Mary Ann Liebert, Inc., is a premier journal dedicated to the rapidly evolving field of biotechnology with a particular focus on its applications in industrial settings. Since its inception in 2006, this influential journal has been a vital resource for researchers and professionals keen on exploring innovative bioprocesses and the sustainable use of biological systems in industry. With an ISSN of 1550-9087 and an E-ISSN of 1931-8421, Industrial Biotechnology maintains a Q3 ranking in the biotechnology category, ranking 216 out of 311 in Scopus, signifying its growing impact in the field despite a current percentile rank of 30. This journal collects and disseminates significant findings that bridge the gap between science and technology, emphasizing ecological sustainability and economic viability in industrial practices. While offering traditional subscription options, it connects readers with cutting-edge advancements that shape modern biotechnology. As you delve into the pages of Industrial Biotechnology, expect to uncover groundbreaking research and pivotal insights that foster the advancement of this vital discipline.

Synthetic and Systems Biotechnology, published by KEAI PUBLISHING LTD, is a pioneering open-access journal that has made significant contributions to the fields of applied microbiology, biotechnology, biomedical engineering, genetics, and structural biology since its inception in 2016. With an ISSN of 2405-805X, this journal is committed to fostering innovative research and interdisciplinary collaboration, providing a platform for the dissemination of high-quality studies that push the boundaries of scientific knowledge. Recognized for its excellence, it holds prestigious Q1 rankings in both Applied Microbiology and Biotechnology as well as Biomedical Engineering in 2023, alongside notable Q2 rankings in Genetics and Structural Biology. Researchers, professionals, and students alike can access cutting-edge research that explores the dynamic interplay between synthetic biology and systems biology, driving advancements that could reshape health, industry, and environmental sustainability. By operating under an open-access model, Synthetic and Systems Biotechnology ensures that new findings are accessible to a global audience, thereby maximizing the impact and reach of the published work and paving the way for future discoveries.

GEN Biotechnology, published by MARY ANN LIEBERT, INC, is a pivotal journal dedicated to advancing the field of biotechnology through the dissemination of high-quality research. With its ISSN 2768-1572 and E-ISSN 2768-1556, this journal seeks to bridge the gap between fundamental biotechnology research and its practical applications across various industries. As a leading publication in the life sciences arena, it emphasizes innovative studies in areas such as genetic engineering, molecular biology, bioinformatics, and synthetic biology. Although currently not open access, GEN Biotechnology offers a platform for researchers, professionals, and students to delve into cutting-edge findings that significantly impact health, agriculture, and environmental sustainability. Its commitment to excellence is underscored by its strive for high visibility within the global research community.